RAB001

LLP2A-Alendronate · ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAB001, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head [Phase 2]

See pricing